Cartalax 20mg – Bioregulator

Cartalax 20mg – Research Bioregulator Peptide

Cartalax is a synthetic bioregulator peptide offered at a 20mg concentration, developed for advanced scientific research in the field of joint and cartilage support. Known for its short-chain structure, Cartalax is used to explore cellular regeneration and age-related changes in connective tissue.

• Product Name: Cartalax 20mg
• Catalogue Number: CART20-031
• Molecular Formula: C₁₂H₁₉N₃O₈
• Molecular Weight: 333.29 g/mol
• Purity: ≥99% (HPLC)
• Form: Lyophilised Solid
• Class: Synthetic Bioregulator Peptide
• Research Area: Joint & Cartilage Studies

Usage and Storage:

Supplied as a lyophilised solid, Cartalax is designed for stability and consistency in laboratory environments. Store refrigerated at 2–8°C. Reconstitution and handling should follow standard laboratory protocols for peptide research.

Scientific Background:

Cartalax belongs to the class of bioregulator peptides developed for potential modulation of tissue-specific processes. It is most commonly studied in relation to joint health, cartilage integrity, and cellular ageing. Research suggests it may support improved cellular function and resilience under degenerative conditions.

Legal and Safety Information:

This product is strictly intended for laboratory research purposes only. It is not a drug, food, or cosmetic, and must not be used for human or veterinary applications.